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Abstract. The direct involvment of the Wilm's tumor sup-
pressor gene (WTl) in Denys-Drash syndrome through 
mutations within exons 8 or 9 has recently been estab-
lished. The absence of such alterations in three patients 
with Frasier syndrome provides a molecular basis for dis-
tinguishing these two syndromes that are associated with 
streak gonads, pseudohermaphroditism and renal failure. 
Introduction 
The association of chronic renal failure with XY gonadal 
dysgenesis is weil known (Drash et al. 1970; Frasier et al. 
1964 ). However, some patients do not develop renal 
Wilm's tumor, but have an increased likehood of develop-
ing gonadoblastoma. These patients have been grouped 
under the generic term "Frasier·syndrome" by Moorthy et 
al. (1987). The recent discovery of the presence of point 
mutations in the newly described Wilm's tumor suppres-
sor gene WTl in 10 independent cases of Denys-Drash 
syndrome (Pelletier et al. 1991) has led us to search for 
such mutations in Frasier syndrome. We report here a se-
quence comparison between an individual with Denys-
Drash syndrome and three patients with Frasier syn-
drome, with respect to WTI exons 8 and 9. 
Materials and methods 
The three Frasier patients (Che, Dei and Mar) suffered nephrotic 
syndrome with important proteinuria. They all underwent renal 
transplantation. Their chromosome analysis revealed 46-XY with 
gonadal dysgenesis. Their gonads were streak gonads and, for Che, 
one of them was tumoral. A bilateral castration was carried out in 
each case. 
The Denys-Drash patient (A 1) bad a female phenotype with XY 
gonadal dysgenesis and severe renal failure. Laboratory investiga-
tions confirmed the nephrotic syndrome with diffuse mesanglial 
sclerosis and a unilateral Wilm's tumorwas discovered. 
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Polymerase chain reaction (PCR) amplifications ofthe TWJ ex-
ons 8 or 9 were carried out using the primer sets W8A:5'-ACA 
GCT GCC AGC AAT GAG AA-3', W8S: 5'-GAG ATC CCC 
AAA AGG AGT ATC A-3 ', and W9A: 5 'CTT TTC CAA TCC 
CTC TCA TCA-3', W9S: 5'-CAT TGT TAG GGC CGA GGC 
TA-3 ', respectively. Primers were designed with respect to the ge-
nomic Wfl sequence described in Gessler et al. (1992). 
A 176-bp PCR product for exon 8 and a 218-bp PCR product 
for exon 9 were obtained after 35 cycles of 30s at 94° C, 30s at 60° 
C, and Imin at 72°C. PCR products were purified by centrifuga-
tion through Spin Bind DNA extraction units (FMC). One tenth of 
the reaction mixture was used for dideoxy-sequencing using a se-
quenase kit (U.S. Biochemical) with IOJ,lmoles of the same 
oligonucleotides as primers according to the method of Casanova 
et al. (1990). 
Single-strand chain polymorphism (SSCP) analysis were per-
formed as described previously (Orita et al. 1989), and the non-de-
naturating gels run under two standard conditions, either at 4°C 
or at room temperature, with 10% glycerol. Prim er sequences 
were: wt-ls, 5'-GGGCGTCCGGGTCI'GAGCCT-3', and wt-1a, 
5'-CCGGAAAAGTGGACAGTGAAGGCG-3" for exon I; wtl-
2s, 5'-CGAGGAGCAGTGCCTGAG-3", and wtl-2a 5'-GCGGA-
GAGTCCCTGGCGC-3', and wt-2s, 5'-CGAGAGCACCGC-
TGACACTG-3', and wt-2a, 5'-GAGAAGGACTCCACITGG-
TTCCG-3' for exon 2; wt-3s, 5'-CCAGGCTCAGGATCTCGT-
GT-3 ', and wt-3a, 5' -AAGGACCCAGACGCAGAGC-3' for exon 
3; wt-4s, 5'-TGCTITIGAAGAAACAGTIGTG-3', and wt-4a, 
5'-GGAAAGGCAATGGAATAGAGA-3' for exon 4; wt-5s, 5'-
GGGcrTTTCACTGGATTCTG-3', and wt-5a, 5'-CCATTT-
GC1TIGCCATCI'CC-3' for exon 5; wt-6s, 5'-GTGAGCCA-
CACTGAGCCTIT-3' and wt-6a, 5'-GGCCGGTAAGTAGGAA-
GAGG-3' for exon 6; wt-7s, 5'-GGCTTAAAGCCTCCCTTCCT-
3', and wt-7a, 5'-TGAGAGCCI'GGAAAAGGAGC-3' forexon 7; 
wt-8s, 5'-GAGATCCCCTITTCCAGTATCA-3', and wt-8a, 5'-
ACAGCTGCCAGCAATGAGAA-3' for exon 8; wt-9s, 5'-CAT-
TGTTAGGGCCGAGGCTA-3', and wt-9a, 5'-CTITICCAA-
TCCCTCTCATCA-3' for exon 9; wt-IOs, 5'-TGTGCCTGT-
CTCifTGTTGC-3' and wt-1 Oa, 5 '-GTICACACACTGTGC-
TGCCT-3' for exon 10. 
Results and discussion 
The four patients were analyzed to determine the presence 
or absence of point mutations in WTl exons 8 or 9. Ge-
nomic DNAs isolated from peripheral blood lymphocytes 
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Fig.l. Direct sequencing of PCR products from exon 9. The Denys-Drash patient A lshows the C ~ T transition, a mutationnot found for 
the Frasier individuals Che. Dei and Mar. The corresponding position of the nucleotide affected by a mutation in the Denys-Drash patient 
(Al) is marked by an arrow. G, A, T. C: sequencing lanes 
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Fig. 2. SSCP analysis of WT I exons 7 and I 0 in Frasier patients. 
No variation was detected in the banding obtained with Che, Dei 
or Mar when compared with normal individualc;; (C) 
were subjected to direct sequencing after amplification 
with the appropriate primers. No mutation could be found 
in exon 8 in each case (data not shown). The individual 
with Denys-Drash syndrome displayed the same hemizy-
gous mutation in exon 9 (Fig. 1) as the majority of patients 
analyzed in Pelletier et al. ( 1991 ). This C to T transition 
converts 394Arg to Trp within the third zinc finger domain 
of WTI and thus potentially affects the DNA-binding 
properties of the resulting transcription factor. On the 
other hand, DNA from all the patients with Frasier syn-
drome showed no mutations in exon 9. 
However, the presence of WT I abnormalities in Frasier 
syndrome cannot be excluded e1sewhere in the gene, al-
though it appears unlikely because of the absence of 
Wilm's tumor development. The DNAs of the three pa-
tients were tested using SSCP assay for alterations in the 
coding region of exons 1-10 of WTI with the exception 
of the 5' half of exon I that is so GC-rich that it cannot be 
amplified reproducibly in our hands. In all reactions, there 
was no difference of the banding pattems compared with 
that seen in several control samples. An example of such 
an SSCP analysis is provided in Fig. 2. However, the 
SSCP method may fail to detect some point mutations and 
has been described with an estimated 80% of point muta-
tions being detectable (Orita et al. 1990). Furthermore, 
large deletions in the sex-determining region of the Y chro-
mosome of such individuals or mutations localized in the 
sex-determining gene SRY have not been detected (Berta 
et al. 1992). Thus, the molecular origin of this syndrome af-
fecting urogenital development remains an open question. 
In conclusion, although the Frasier and Denys-Drash 
syndromes sometimes appear to be difficult to distinguish 
clinically, our results provide a possible molecular basis 
for separating these two syndromes on a genetic basis. 
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